Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR

E A. Verschuuren, S Stevens, B B. Hanekamp, C De Boer, M C. Harmsen, J M. Middeldorp, G Koeter, T H. The, W Van Der Bij

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)199
JournalJournal of Heart and Lung Transplantation
Volume20
Issue number2
Publication statusPublished - Feb 2001

Cite this